COVID-19 Research Paper Volume 12, Issue 19 pp 18878—18888
Efficacy and safety of tocilizumab in COVID-19 patients
Figure 1. The values of maximum temperature, CRP, and IL-6 levels before and after tocilizumab treatment in COVID-19 patients. (A) The fever returned toward normal in most patients treated conventionally or with tocilizumab. (B) CRP levels decreased significantly after tocilizumab treatment and returned to normal in most conventionally treated patients. (C) IL-6 increased significantly after tocilizumab treatment in most patients.